Determination of brain iron content in patients with Parkinson's disease using magnetic susceptibility imaging

Neuroscience Bulletin

Volumn 25, Issue 6, 2009, Pages 353-360

  Zhang, Wei ^a   Sun, Sheng Gan ^a   Jiang, Yu Hong ^a   Qiao, Xian ^a   Sun, Xin ^a   Wu, Yan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Iron deposition; Parkinson's disease; Phase radians; Susceptibility weighted imaging

Indexed keywords

IRON;

ADULT; AGED; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; GRAY MATTER; HUMAN; MALE; NEUROIMAGING; PARKINSON DISEASE; PATIENT MONITORING; PUTAMEN; QUANTITATIVE ANALYSIS; RED NUCLEUS; SUBSTANTIA NIGRA; SUSCEPTIBILITY WEIGHTED IMAGING; SYMPTOM; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; COGNITION DISORDERS; DYSKINESIAS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 72349088723     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12264-009-0225-8     Document Type: Article

References (28)

1. A.H. Schapira 2006 Etiology of Parkinson's disease Neurology 66 S10 23 16717248
2. K.C. Taylor C. Counsell 2006 Is it Parkinson's disease, and if not, what is it? Pract Neurol 6 154 165 10.1136/jnnp.2006.091835
3. P.D. Griffiths B.R. Dobson G.R. Jones D.T. Clarke 1999 Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy Brain 122 Pt4 667 673 10.1093/brain/122.4.667 10219780 (Pubitemid 29158775)
4. P. Kosta M.I. Argyropoulou S. Markoula S. Konitsiotis 2006 MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease J Neurol 253 26 32 10.1007/s00415-005-0914-9 15981079 (Pubitemid 43157384)
5. E.M. Haacke N.Y. Cheng M.J. House Q. Liu J. Neelavalli R.J. Ogg, et al. 2005 Imaging iron stores in the brain using magnetic resonance imaging Magn Reson Imaging 23 1 25 10.1016/j.mri.2004.10.001 1:CAS:528:DC%2BD2MXhslWmtL0%3D 15733784 (Pubitemid 40269946)
6. G. Bartzokis T.A. Tishler P.H. Lu P. Villablanca L.L. Altshuler M. Carter, et al. 2007 Brain ferritin iron may influence age- and gender-related risks of neurodegeneration Neurobiol Aging 28 414 423 10.1016/j.neurobiolaging. 2006.02.005 1:CAS:528:DC%2BD2sXhtlant7w%3D 16563566 (Pubitemid 46177391)
7. D. Berg M. Gerlach M. Youdim P. Villablanca L.L. Altshuler M. Carter, et al. 2001 Brain iron pathways and their relevance to Parkinson's disease J Neurochem 79 225 236 10.1046/j.1471-4159.2001.00608.x 1:CAS:528: DC%2BD3MXnvFSmsr8%3D 11677250 (Pubitemid 32988938)
8. M. Gotz K. Double M. Gerlach M. Youdim P. Riederer 2004 The relevance of iron in the pathogenesis of Parkinson's disease Ann N Y Acad Sci 1012 193 208 10.1196/annals.1306.017 15105267 (Pubitemid 38455479)
9. A. Michell S. Lewis T. Foltynie R. Barker 2004 Biomarkers and Parkinson's disease Ann Neurol 35 204 210
10. G. Bartzokis T.A. Tishler I.S. Shin P.H. Lu J.L. Cummings 2004 Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases Ann N Y Acad Sci 1012 224 236 10.1196/annals.1306.019 1:CAS:528: DC%2BD2cXjvVOmsrc%3D 15105269 (Pubitemid 38453528)
11. S.M. Sadrzadeh Y. Saffari 2004 Iron and brain disorders Am J Clin Pathol 121 S64 S70 10.1309/XLNDTE289WAQYK0Y 15298151
12. J.C. Sipe P. Lee E. Beutler 2002 Brain iron metabolism and neurodegenerative disorders Dev Neurosci 24 188 196 10.1159/000065701 1:CAS:528:DC%2BD38Xot1Ois7w%3D 12401958 (Pubitemid 36151450)
13. P. Vermersch D. Leys J.P. Pruvo J. Clarisse H. Petit 1992 Parkinson's disease and basal ganglia calcifications: prevalence and clinicoradiological correlations Clin Neurol Neurosurg 94 213 217 10.1016/0303-8467(92)90091-G 1:STN:280:DyaK3s%2FgvFersA%3D%3D 1327610
14. E.M. Haacke Y. Xu Y.C. Cheng J.R. Reichenbach 2004 Susceptibility weighted imaging (SWI) Magn Reson Med 52 612 618 10.1002/mrm.20198 15334582 (Pubitemid 39108975)
15. R.J. Ogg J.W. Langston E.M. Haacke R.G. Steen J.S. Taylor 1999 The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration Magn Reson Imaging 17 1141 1148 10.1016/S0730-725X(99)00017-X 1:STN:280:DyaK1MvivVShsA%3D%3D 10499676 (Pubitemid 29444639)
16. K.A. Tong S. Ashwal B.A. Holshouser L.A. Shutter G. Herigault E.M. Haacke 2003 Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results Radiology 227 332 339 10.1148/radiol.2272020176 12732694 (Pubitemid 36514744)
17. Y. Wang Y. Yu D. Li K.T. Bae J.J. Brown W. Lin, et al. 2000 Artery and vein separation using susceptibility-dependent phase in contrastenhanced MRA J Magn Reson Imaging 12 661 670 10.1002/1522-2586(200011)12:5<661::AID- JMRI2>3.0.CO;2-L 1:STN:280:DC%2BD3M%2FltFCmsg%3D%3D 11050635 (Pubitemid 30808462)
18. J.R. Reichenbach R. Venkatesan D.A. Yablonskiy M.R. Thompson S. Lai E.M. Haacke 1997 Theory and application of static field inhomogeneity effects in gradient-echo imaging J Magn Reson Imaging 7 266 279 10.1002/jmri.1880070203 1:STN:280:DyaK2s3ksF2gtQ%3D%3D 9090577 (Pubitemid 28356957)
19. K. Gurleyik E.M. Haacke 2002 Quantification of errors in volume measurements of the caudate nucleus using magnetic resonance imaging Magn Reson Imaging 15 353 363 10.1002/jmri.10083 (Pubitemid 34252397)
20. W.R. Martin M. Wieler M. Gee 2008 Midbrain iron content in early Parkinson disease: a potential biomarker of disease status Neurology 70 1411 1417 10.1212/01.wnl.0000286384.31050.b5 1:CAS:528:DC%2BD1cXksFantr8%3D 18172063
21. J.F. Schenck E.A. Zimmerman 2004 High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 17 7 433 445 10.1002/nbm.922 1:CAS:528:DC%2BD2MXivFGr 15523705 (Pubitemid 39549421)
22. J. Vymazal A. Righini R.A. Brooks M. Canesi C. Mariani M. Leonardi, et al. 1999 T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content Radiology 211 489 495 1:STN:280:DyaK1M3ksFaitQ%3D%3D 10228533
23. R. Philippe B. Emmanuel P. Henri V. Francois K. Yad Chazot. Guy 1995 Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease Arch Neurol. 52 583 588
24. J.M. Graham M.N. Paley R.A. Grunewald N. Hoggard P.D. Griffiths 2000 Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence Brain 123 Pt12 2423 2431 10.1093/brain/123.12.2423 11099445
25. R. Levy L.N. Hazrati M.T. Herrero M. Vila O.K. Hassani M. Mouroux, et al. 1997 Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states Neuroscience 76 2 335 343 10.1016/S0306-4522(96)00409-5 1:CAS:528:DyaK2sXnt1KmsA%3D%3D 9015319 (Pubitemid 27008465)
26. P.D. Griffiths A.R. Crossman 1993 Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease Dementia 4 61 65 1:STN:280:DyaK3szmsVGjtw%3D%3D 8358514
27. L.I. Wallis M.N. Paley J.M. Graham R.A. Grünewald E.L. Wignall H.M. Joy, et al. 2008 MRI assessment of basal ganglia iron deposition in Parkinson's disease J Magn Reson Imaging 28 5 1061 1067 10.1002/jmri.21563 18972346
28. H.T. Atasoy O. Nuyan T. Tunc M. Yorubulut A.E. Unal L.E. Inan 2004 T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores Neurol India 52 3 332 337 15472421